PubRank

Naveed Sattar

Author PubWeight™ 479.26‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009 10.58
2 Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 2009 10.55
3 Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet 2011 9.07
4 Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA 2011 8.24
5 Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants. Arch Intern Med 2010 7.49
6 C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012 6.39
7 Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet 2004 6.24
8 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 2013 5.23
9 Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials. Arch Intern Med 2012 5.12
10 The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet 2012 4.87
11 Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet 2012 4.73
12 Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet 2016 4.49
13 Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data. Hepatology 2010 4.43
14 A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet 2012 4.37
15 Association of maternal weight gain in pregnancy with offspring obesity and metabolic and vascular traits in childhood. Circulation 2010 4.12
16 Lipid-related markers and cardiovascular disease prediction. JAMA 2012 3.91
17 Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease. N Engl J Med 2016 3.88
18 IL-33 reduces the development of atherosclerosis. J Exp Med 2008 3.59
19 C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 2002 3.59
20 Serum chloride is an independent predictor of mortality in hypertensive patients. Hypertension 2013 3.33
21 Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet 2012 3.21
22 Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 2002 3.00
23 Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab 2002 2.80
24 Insight into the nature of the CRP-coronary event association using Mendelian randomization. Int J Epidemiol 2006 2.70
25 Associations of gestational weight gain with maternal body mass index, waist circumference, and blood pressure measured 16 y after pregnancy: the Avon Longitudinal Study of Parents and Children (ALSPAC). Am J Clin Nutr 2011 2.67
26 Metabolic syndrome and incident diabetes: current state of the evidence. Diabetes Care 2008 2.66
27 Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Ann Rheum Dis 2012 2.54
28 Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children. Circulation 2012 2.54
29 Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol 2010 2.46
30 Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis. Arterioscler Thromb Vasc Biol 2007 2.45
31 Association between general and central adiposity in childhood, and change in these, with cardiovascular risk factors in adolescence: prospective cohort study. BMJ 2010 2.41
32 B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circulation 2009 2.37
33 A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J Immunol 2003 2.37
34 The relationship between metabolic risk factors and incident cardiovascular disease in Europeans, South Asians, and African Caribbeans: SABRE (Southall and Brent Revisited) -- a prospective population-based study. J Am Coll Cardiol 2013 2.36
35 Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension. PLoS Genet 2010 2.24
36 Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors. Arch Intern Med 2011 2.24
37 Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis. Diabetes Care 2009 2.23
38 Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. J Am Coll Cardiol 2013 2.18
39 Obesity is associated with fatal coronary heart disease independently of traditional risk factors and deprivation. Heart 2011 2.17
40 Ethnicity and prediction of cardiovascular disease: performance of QRISK2 and Framingham scores in a U.K. tri-ethnic prospective cohort study (SABRE--Southall And Brent REvisited). Heart 2013 2.12
41 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016 2.09
42 A genome-wide association study reveals variants in ARL15 that influence adiponectin levels. PLoS Genet 2009 2.09
43 The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide to predict cardiovascular events and death in patients with type 2 diabetes. Diabetes Care 2013 2.07
44 Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension 2004 1.92
45 Associations between dietary fiber and inflammation, hepatic function, and risk of type 2 diabetes in older men: potential mechanisms for the benefits of fiber on diabetes risk. Diabetes Care 2009 1.86
46 Association between genetic variants on chromosome 15q25 locus and objective measures of tobacco exposure. J Natl Cancer Inst 2012 1.83
47 Obesity and risk of incident heart failure in older men with and without pre-existing coronary heart disease: does leptin have a role? J Am Coll Cardiol 2011 1.80
48 Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circ Res 2010 1.80
49 Type 2 diabetes and cardiovascular disease in South Asians. Prim Care Diabetes 2010 1.78
50 Inflammation and ischaemic stroke. Curr Opin Neurol 2007 1.77
51 Multiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease. Circulation 2013 1.77
52 Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women. J Clin Endocrinol Metab 2005 1.74
53 Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence. Clin Endocrinol (Oxf) 2008 1.73
54 Adiposity and cardiovascular risk factors in a large contemporary population of pre-pubertal children. Eur Heart J 2010 1.73
55 Childhood obesity and vascular phenotypes: a population study. J Am Coll Cardiol 2012 1.72
56 Lipid-modifying therapies and risk of pancreatitis: a meta-analysis. JAMA 2012 1.71
57 Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up. Eur Heart J 2010 1.69
58 Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study. PLoS Med 2012 1.69
59 Role for TNF in atherosclerosis? Lessons from autoimmune disease. Nat Rev Cardiol 2009 1.68
60 Early emergence of ethnic differences in type 2 diabetes precursors in the UK: the Child Heart and Health Study in England (CHASE Study). PLoS Med 2010 1.68
61 Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis 2004 1.66
62 Evaluation of C-reactive protein prior to and on-treatment as a predictor of benefit from atorvastatin: observations from the Anglo-Scandinavian Cardiac Outcomes Trial. Eur Heart J 2011 1.66
63 The effect of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: a meta-analysis. Semin Arthritis Rheum 2011 1.63
64 Adipokines and risk of type 2 diabetes in older men. Diabetes Care 2007 1.63
65 Maternal adiposity--a determinant of perinatal and offspring outcomes? Nat Rev Endocrinol 2012 1.62
66 Genetic variation at the SLC23A1 locus is associated with circulating concentrations of L-ascorbic acid (vitamin C): evidence from 5 independent studies with >15,000 participants. Am J Clin Nutr 2010 1.61
67 Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index. Int J Epidemiol 2011 1.61
68 Paradoxical elevation in adiponectin concentrations in women with preeclampsia. Hypertension 2003 1.60
69 Adipocytokines and risk of stroke in older people: a nested case-control study. Int J Epidemiol 2008 1.59
70 Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin Sci (Lond) 2008 1.59
71 IQ, educational attainment, memory and plasma lipids: associations with apolipoprotein E genotype in 5995 children. Biol Psychiatry 2011 1.59
72 The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes. Int J Epidemiol 2011 1.58
73 Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. Arch Intern Med 2007 1.57
74 An evaluation of risk factors for major adverse cardiovascular events during tocilizumab therapy. Arthritis Rheumatol 2015 1.57
75 Circulating concentrations of insulin markers and coronary heart disease: a quantitative review of 19 Western prospective studies. Eur Heart J 2007 1.55
76 N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS. Eur Heart J 2012 1.55
77 Changes in booking body mass index over a decade: retrospective analysis from a Glasgow Maternity Hospital. BJOG 2005 1.55
78 Nonalcoholic fatty liver disease, liver fibrosis, and cardiometabolic risk factors in adolescence: a cross-sectional study of 1874 general population adolescents. J Clin Endocrinol Metab 2014 1.55
79 ABC of obesity. Obesity--time to wake up. BMJ 2006 1.55
80 A complex intervention to improve pregnancy outcome in obese women; the UPBEAT randomised controlled trial. BMC Pregnancy Childbirth 2014 1.55
81 Evaluation of C-reactive protein before and on-treatment as a predictor of benefit of atorvastatin: a cohort analysis from the Anglo-Scandinavian Cardiac Outcomes Trial lipid-lowering arm. J Am Coll Cardiol 2013 1.54
82 Blood biomarkers for the diagnosis of acute cerebrovascular diseases: a prospective cohort study. Cerebrovasc Dis 2011 1.53
83 Genetic determinants of metabolic syndrome components in the stroke-prone spontaneously hypertensive rat. J Hypertens 2005 1.53
84 Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study. Obes Res 2002 1.52
85 Lipotoxicity in obese pregnancy and its potential role in adverse pregnancy outcome and obesity in the offspring. Clin Sci (Lond) 2010 1.50
86 CVD risk factors and ethnicity--a homogeneous relationship? Atheroscler Suppl 2006 1.50
87 Preeclampsia and gestational hypertension are associated with childhood blood pressure independently of family adiposity measures: the Avon Longitudinal Study of Parents and Children. Circulation 2010 1.49
88 Pravastatin and cognitive function in the elderly. Results of the PROSPER study. J Neurol 2009 1.47
89 Genetic variation in PCAF, a key mediator in epigenetics, is associated with reduced vascular morbidity and mortality: evidence for a new concept from three independent prospective studies. Heart 2010 1.46
90 25-Hydroxyvitamin D is lower in deprived groups, but is not associated with carotid intima media thickness or plaques: results from pSoBid. Atherosclerosis 2012 1.46
91 Ethnic differences in carotid intima-media thickness between UK children of black African-Caribbean and white European origin. Stroke 2012 1.46
92 Genome-wide association study for circulating tissue plasminogen activator levels and functional follow-up implicates endothelial STXBP5 and STX2. Arterioscler Thromb Vasc Biol 2014 1.45
93 The value of N-terminal pro-B-type natriuretic peptide in determining antihypertensive benefit: observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Hypertension 2013 1.44
94 Vitamin D and chronic disease prevention. BMJ 2014 1.43
95 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Rev Esp Cardiol (Engl Ed) 2016 1.42
96 N-terminal pro-brain natriuretic peptide and cognitive decline in older adults at high cardiovascular risk. Ann Neurol 2014 1.41
97 Birthweight and risk markers for type 2 diabetes and cardiovascular disease in childhood: the Child Heart and Health Study in England (CHASE). Diabetologia 2014 1.40
98 Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions. Ann Rheum Dis 2012 1.33
99 Accelerated telomere attrition is associated with relative household income, diet and inflammation in the pSoBid cohort. PLoS One 2011 1.33
100 Cardiovascular biomarkers and vascular function during childhood in the offspring of mothers with hypertensive disorders of pregnancy: findings from the Avon Longitudinal Study of Parents and Children. Eur Heart J 2011 1.31
101 Association of genetic Loci with glucose levels in childhood and adolescence: a meta-analysis of over 6,000 children. Diabetes 2011 1.31
102 First-trimester prediction of gestational diabetes mellitus: examining the potential of combining maternal characteristics and laboratory measures. Diabetes 2010 1.30
103 Mendelian randomization study of B-type natriuretic peptide and type 2 diabetes: evidence of causal association from population studies. PLoS Med 2011 1.30
104 Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis 2006 1.29
105 Insulin resistance and truncal obesity as important determinants of the greater incidence of diabetes in Indian Asians and African Caribbeans compared with Europeans: the Southall And Brent REvisited (SABRE) cohort. Diabetes Care 2012 1.29
106 Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial. J Clin Endocrinol Metab 2002 1.28
107 Unraveling the directional link between adiposity and inflammation: a bidirectional Mendelian randomization approach. J Clin Endocrinol Metab 2009 1.27
108 Management of obesity: summary of SIGN guideline. BMJ 2010 1.26
109 ABC of obesity. Assessment of obesity and its clinical implications. BMJ 2006 1.26
110 Effect of socioeconomic status on mortality among people with type 2 diabetes: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetes Care 2011 1.26
111 Statins and the risk of new-onset diabetes: a review of recent evidence. Curr Opin Lipidol 2011 1.26
112 Association between BMI measured within a year after diagnosis of type 2 diabetes and mortality. Diabetes Care 2012 1.25
113 Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome. Lancet 2003 1.24
114 Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk. J Clin Endocrinol Metab 2012 1.23
115 Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk? Ann Rheum Dis 2009 1.22
116 Changes in ponderal index and body mass index across childhood and their associations with fat mass and cardiovascular risk factors at age 15. PLoS One 2010 1.22
117 Defining obesity cut-off points for migrant South Asians. PLoS One 2011 1.22
118 ABC of obesity. Obesity and cancer. BMJ 2006 1.22
119 Unanswered questions over NHS health checks. BMJ 2010 1.22
120 Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm. Nat Rev Rheumatol 2013 1.20
121 Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms. Circulation 2009 1.20
122 The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic stroke. Stroke 2011 1.19
123 N-terminal pro-brain natriuretic Peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease. J Am Coll Cardiol 2011 1.18
124 Differences in atherosclerosis according to area level socioeconomic deprivation: cross sectional, population based study. BMJ 2009 1.17
125 Obesity in pregnancy: prevalence and metabolic consequences. Semin Fetal Neonatal Med 2009 1.17
126 A prospective analysis of elevated fasting glucose levels and cognitive function in older people: results from PROSPER and the Rotterdam Study. Diabetes 2010 1.17
127 Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide. Eur Heart J 2007 1.17
128 Developing a complex intervention for diet and activity behaviour change in obese pregnant women (the UPBEAT trial); assessment of behavioural change and process evaluation in a pilot randomised controlled trial. BMC Pregnancy Childbirth 2013 1.16
129 First-trimester circulating 25-hydroxyvitamin D levels and development of gestational diabetes mellitus. Diabetes Care 2011 1.15
130 Reduced incidence of lower-extremity amputations in people with diabetes in Scotland: a nationwide study. Diabetes Care 2012 1.14
131 Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial. Clin Endocrinol (Oxf) 2006 1.13
132 High adiponectin and increased risk of cardiovascular disease and mortality in asymptomatic older men: does NT-proBNP help to explain this association? Eur J Cardiovasc Prev Rehabil 2011 1.13
133 Microvascular dysfunction: a link between pre-eclampsia and maternal coronary heart disease. BJOG 2003 1.12
134 A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function. PLoS Genet 2013 1.12
135 Recruiting South Asians to a lifestyle intervention trial: experiences and lessons from PODOSA (Prevention of Diabetes & Obesity in South Asians). Trials 2011 1.11
136 Plasmacytoid dendritic cells play a key role in promoting atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2012 1.11
137 Alkaline phosphatase, serum phosphate, and incident cardiovascular disease and total mortality in older men. Arterioscler Thromb Vasc Biol 2013 1.11
138 Hypertensive disorders of pregnancy and cardiometabolic health in adolescent offspring. Hypertension 2013 1.10
139 Cerebral microbleeds are predictive of mortality in the elderly. Stroke 2011 1.10
140 UK-born Pakistani-origin infants are relatively more adipose than white British infants: findings from 8704 mother-offspring pairs in the Born-in-Bradford prospective birth cohort. J Epidemiol Community Health 2013 1.10
141 Allopurinol use yields potentially beneficial effects on inflammatory indices in those with recent ischemic stroke: a randomized, double-blind, placebo-controlled trial. Stroke 2008 1.08
142 Association between younger age when first overweight and increased risk for CKD. J Am Soc Nephrol 2013 1.08
143 Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis. PLoS Med 2009 1.08
144 Lung function and risk of type 2 diabetes and fatal and nonfatal major coronary heart disease events: possible associations with inflammation. Diabetes Care 2010 1.08
145 Apolipoprotein e genotype, plasma cholesterol, and cancer: a Mendelian randomization study. Am J Epidemiol 2009 1.07
146 Diabetes risk and amino acid profiles: cross-sectional and prospective analyses of ethnicity, amino acids and diabetes in a South Asian and European cohort from the SABRE (Southall And Brent REvisited) Study. Diabetologia 2015 1.07
147 Fat oxidation, fitness and skeletal muscle expression of oxidative/lipid metabolism genes in South Asians: implications for insulin resistance? PLoS One 2010 1.06
148 Comment on Shah et al. Cardiovascular complications and mortality after diabetes diagnosis for South Asian and Chinese patients: a population-based cohort study. Diabetes care 2013;36:2670-2676. Diabetes Care 2014 1.06
149 Effects of prior moderate exercise on postprandial metabolism and vascular function in lean and centrally obese men. J Am Coll Cardiol 2004 1.06
150 Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation. Clin Sci (Lond) 2005 1.06
151 The associations of physical activity and adiposity with alanine aminotransferase and gamma-glutamyltransferase. Am J Epidemiol 2005 1.05
152 Score based on hypoalbuminemia and elevated C-reactive protein predicts survival in patients with advanced gastrointestinal cancer. Nutr Cancer 2004 1.05
153 Low-dose docosahexaenoic acid lowers diastolic blood pressure in middle-aged men and women. J Nutr 2007 1.05
154 Cardiometabolic aspects of the polycystic ovary syndrome. Endocr Rev 2012 1.05
155 Genetic predictors of fibrin D-dimer levels in healthy adults. Circulation 2011 1.05
156 ABC of obesity. Obesity and reproduction. BMJ 2006 1.04
157 Inflammation and endothelial activation is evident at birth in offspring of mothers with type 1 diabetes. Diabetes 2007 1.04
158 Associations of gestational diabetes, existing diabetes, and glycosuria with offspring obesity and cardiometabolic outcomes. Diabetes Care 2011 1.04
159 Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 2006 1.04
160 Blood pressure variability and cardiovascular risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). PLoS One 2012 1.03
161 Adiponectin, diabetes, and coronary heart disease in older persons: unraveling the paradox. J Clin Endocrinol Metab 2008 1.03
162 Achieved levels of HbA1c and likelihood of hospital admission in people with type 1 diabetes in the Scottish population: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetes Care 2011 1.03
163 Sitting time and waist circumference are associated with glycemia in U.K. South Asians: data from 1,228 adults screened for the PODOSA trial. Diabetes Care 2011 1.02
164 Influence of adiposity on insulin resistance and glycemia markers among U.K. Children of South Asian, black African-Caribbean, and white European origin: child heart and health study in England. Diabetes Care 2013 1.02
165 Maternal docosahexaenoic acid supplementation and fetal accretion. Br J Nutr 2003 1.01
166 Γ-glutamyltransferase, hepatic enzymes, and risk of incident heart failure in older men. Arterioscler Thromb Vasc Biol 2012 1.01
167 Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2003 1.01
168 Genetic variation in the 15q25 nicotinic acetylcholine receptor gene cluster (CHRNA5-CHRNA3-CHRNB4) interacts with maternal self-reported smoking status during pregnancy to influence birth weight. Hum Mol Genet 2012 1.01
169 Leptin predicts diabetes but not cardiovascular disease: results from a large prospective study in an elderly population. Diabetes Care 2008 1.01
170 Replication of LDL GWAs hits in PROSPER/PHASE as validation for future (pharmaco)genetic analyses. BMC Med Genet 2011 1.00
171 Triglycerides and coronary heart disease: have recent insights yielded conclusive answers? Curr Opin Lipidol 2009 1.00
172 Implementation of proteomic biomarkers: making it work. Eur J Clin Invest 2012 1.00
173 Does low to moderate alcohol intake protect against cognitive decline in older people? J Am Geriatr Soc 2008 0.99
174 Adiponectin in childhood. Int J Pediatr Obes 2008 0.99
175 Depot-specific steroidogenic gene transcription in human adipose tissue. Clin Endocrinol (Oxf) 2008 0.98
176 Leptin and coronary heart disease risk: prospective case control study of British women. Obesity (Silver Spring) 2007 0.98
177 Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program. Diabetes Care 2009 0.98
178 Strikingly low circulating CRP concentrations in ultramarathon runners independent of markers of adiposity: how low can you go? Arterioscler Thromb Vasc Biol 2003 0.98
179 Psychological, social and biological determinants of ill health (pSoBid): study protocol of a population-based study. BMC Public Health 2008 0.97
180 Tissue plasminogen activator, von Willebrand factor, and risk of type 2 diabetes in older men. Diabetes Care 2008 0.97
181 Ethnic differences in aortic pulse wave velocity occur in the descending aorta and may be related to vitamin D. Hypertension 2011 0.97
182 Resting heart rate and incident heart failure and cardiovascular mortality in older adults: role of inflammation and endothelial dysfunction: the PROSPER study. Eur J Heart Fail 2012 0.97
183 Liver X receptor agonism promotes articular inflammation in murine collagen-induced arthritis. Arthritis Rheum 2009 0.96
184 Association of visit-to-visit variability in blood pressure with cognitive function in old age: prospective cohort study. BMJ 2013 0.96
185 Socio-economic position and type 2 diabetes risk factors: patterns in UK children of South Asian, black African-Caribbean and white European origin. PLoS One 2012 0.96
186 N-terminal pro brain natriuretic peptide but not copeptin improves prediction of heart failure over other routine clinical risk parameters in older men with and without cardiovascular disease: population-based study. Eur J Heart Fail 2013 0.95
187 The association between insulin levels and cortical bone: findings from a cross-sectional analysis of pQCT parameters in adolescents. J Bone Miner Res 2012 0.95
188 Integrating information from novel risk factors with calculated risks: the critical impact of risk factor prevalence. Circulation 2011 0.94
189 Elimination of electrically induced iontophoretic artefacts: implications for non-invasive assessment of peripheral microvascular function. J Vasc Res 2002 0.94
190 Soluble ST2 associates with diabetes but not established cardiovascular risk factors: a new inflammatory pathway of relevance to diabetes? PLoS One 2012 0.94
191 ABC of obesity. Obesity--can we turn the tide? BMJ 2006 0.93
192 Objectively measured physical activity and its association with adiponectin and other novel metabolic markers: a longitudinal study in children (EarlyBird 38). Diabetes Care 2008 0.93
193 Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment. Fertil Steril 2005 0.93
194 Microvascular function, metabolic syndrome, and novel risk factor status in women with cardiac syndrome X. Am J Cardiol 2006 0.92
195 Programming of adiposity in offspring of mothers with type 1 diabetes at age 7 years. Diabetes Care 2010 0.92
196 Circulating concentrations of "free" leptin in relation to fat mass and appetite in gastrointestinal cancer patients. Nutr Cancer 2002 0.92
197 Early life socioeconomic adversity is associated in adult life with chronic inflammation, carotid atherosclerosis, poorer lung function and decreased cognitive performance: a cross-sectional, population-based study. BMC Public Health 2011 0.92
198 Clinical and subclinical macrovascular disease as predictors of cognitive decline in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care 2013 0.91
199 Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker. Eur J Heart Fail 2006 0.91
200 The effects of tumor necrosis factor inhibitors on cardiovascular risk in rheumatoid arthritis. Curr Pharm Des 2012 0.91
201 Associations of 25-hydroxyvitamin D2 and D3 with cardiovascular risk factors in childhood: cross-sectional findings from the Avon Longitudinal Study of Parents and Children. J Clin Endocrinol Metab 2012 0.91
202 Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses. J Clin Endocrinol Metab 2005 0.90
203 Interaction of personality traits with social deprivation in determining mental wellbeing and health behaviours. J Public Health (Oxf) 2012 0.90
204 ABC of obesity. Management: Part I--behaviour change, diet, and activity. BMJ 2006 0.90
205 BMI and mortality among adults with incident type 2 diabetes. N Engl J Med 2014 0.90
206 Circulating interleukin-10 and risk of cardiovascular events: a prospective study in the elderly at risk. Arterioscler Thromb Vasc Biol 2011 0.90
207 Adiponectin and its association with bone mass accrual in childhood. J Bone Miner Res 2010 0.89
208 Effects of a moderate exercise session on postprandial lipoproteins, apolipoproteins and lipoprotein remnants in middle-aged men. Atherosclerosis 2005 0.89
209 Low birth weight, later renal function, and the roles of adulthood blood pressure, diabetes, and obesity in a British birth cohort. Kidney Int 2013 0.89
210 Long-term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). PLoS One 2013 0.89
211 Pregnancy glycaemia and cord-blood levels of insulin and leptin in Pakistani and white British mother-offspring pairs: findings from a prospective pregnancy cohort. Diabetologia 2014 0.88
212 Do ethnic differences in cord blood leptin levels differ by birthweight category? Findings from the Born in Bradford cohort study. Int J Epidemiol 2014 0.88
213 IGF-1 and leptin associate with fetal HDL cholesterol at birth: examination in offspring of mothers with type 1 diabetes. Diabetes 2007 0.88
214 Effects of acquired obesity on endothelial function in monozygotic twins. Obesity (Silver Spring) 2006 0.88
215 Inflammatory suppression rapidly attenuates microvascular dysfunction in rheumatoid arthritis. Atherosclerosis 2006 0.88
216 The relationship between reduced vitamin antioxidant concentrations and the systemic inflammatory response in patients with common solid tumours. Clin Nutr 2002 0.88
217 The association of fasting insulin, glucose, and lipids with bone mass in adolescents: findings from a cross-sectional study. J Clin Endocrinol Metab 2012 0.88
218 Benefits of salmon eating on traditional and novel vascular risk factors in young, non-obese healthy subjects. Atherosclerosis 2006 0.88
219 "Anti-inflammatory" drugs and their effects on type 2 diabetes. Diabetes Technol Ther 2006 0.88
220 Vitamin D deficiency is common in patients with RA and linked to disease activity, but circulating levels are unaffected by TNFα blockade: results from a prospective cohort study. Ann Rheum Dis 2010 0.87
221 Tumour necrosis factor {alpha} blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study. Ann Rheum Dis 2009 0.87
222 Novel antecedent plasma biomarkers of cardiovascular disease: improved evaluation methods and comparator benchmarks raise the bar. Curr Opin Lipidol 2008 0.87
223 Low triglyceride, not low cholesterol concentration, independently predicts poor outcome following acute stroke. Cerebrovasc Dis 2003 0.87
224 Ethnic differences in associations between fat deposition and incident diabetes and underlying mechanisms: the SABRE study. Obesity (Silver Spring) 2015 0.87
225 Activation of hemostasis and decline in cognitive function in older people. Arterioscler Thromb Vasc Biol 2009 0.87
226 Anti-müllerian hormone is not associated with cardiometabolic risk factors in adolescent females. PLoS One 2013 0.87
227 Evidence for tissue selectivity of the synthetic androgen 7 alpha-methyl-19-nortestosterone in hypogonadal men. J Clin Endocrinol Metab 2003 0.87
228 Intergenerational change and familial aggregation of body mass index. Eur J Epidemiol 2011 0.87
229 Cardiovascular and metabolic risks in psoriasis and psoriatic arthritis: pragmatic clinical management based on available evidence. Ann Rheum Dis 2012 0.87
230 ABC of obesity: obesity and vascular disease. BMJ 2006 0.87
231 Human placental peroxisome proliferator-activated receptor delta and gamma expression in healthy pregnancy and in preeclampsia and intrauterine growth restriction. J Soc Gynecol Investig 2005 0.87
232 Existing maternal obesity guidelines may increase inequalities between ethnic groups: a national epidemiological study of 502,474 births in England. BMC Pregnancy Childbirth 2012 0.87
233 The incidence and risk factors for new onset atrial fibrillation in the PROSPER study. Europace 2011 0.86
234 The systemic inflammatory response predicts overall and cancer specific survival in patients with malignant lymphoma. Med Sci Monit 2005 0.86
235 Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases? Arthritis Res Ther 2005 0.86
236 Divergent metabolic and vascular phenotypes in pre-eclampsia and intrauterine growth restriction: relevance of adiposity. J Hypertens 2004 0.86
237 Circulating 25OHD, dietary vitamin D, PTH, and calcium associations with incident cardiovascular disease and mortality: the MIDSPAN Family Study. J Clin Endocrinol Metab 2012 0.86
238 Early-life overweight trajectory and CKD in the 1946 British birth cohort study. Am J Kidney Dis 2013 0.86
239 High Innate Production Capacity of Proinflammatory Cytokines Increases Risk for Death from Cancer: Results of the PROSPER Study. Clin Cancer Res 2009 0.86
240 Serum leptin and cognitive function in people with type 2 diabetes. Neurobiol Aging 2012 0.85
241 Revisiting the J shaped curve, exploring the association between cardiovascular risk factors and concurrent depressive symptoms in patients with cardiometabolic disease: Findings from a large cross-sectional study. BMC Cardiovasc Disord 2014 0.85
242 Lack of effect of TNFalpha blockade therapy on circulating adiponectin levels in patients with autoimmune disease: results from two independent prospective studies. Ann Rheum Dis 2009 0.85
243 Adiposity, adipokines, and risk of incident stroke in older men. Stroke 2012 0.85
244 Socioeconomic deprivation and cortical morphology: psychological, social, and biological determinants of ill health study. Psychosom Med 2013 0.85
245 Genome-wide study of gene variants associated with differential cardiovascular event reduction by pravastatin therapy. PLoS One 2012 0.84
246 Are lipid ratios less susceptible to change with systemic inflammation than individual lipid components in patients with rheumatoid arthritis? Angiology 2010 0.84
247 Effect of prior moderate exercise on postprandial metabolism in men with type 2 diabetes: heterogeneity of responses. Atherosclerosis 2006 0.84
248 Association of N-terminal pro-brain natriuretic peptide with cognitive function and depression in elderly people with type 2 diabetes. PLoS One 2012 0.84
249 Associations of childhood 25-hydroxyvitamin D2 and D3 and cardiovascular risk factors in adolescence: prospective findings from the Avon Longitudinal Study of Parents and Children. Eur J Prev Cardiol 2012 0.84
250 Factors critical to iontophoretic assessment of vascular reactivity: implications for clinical studies of endothelial dysfunction. J Cardiovasc Pharmacol 2002 0.83
251 Distribution of adiponectin, leptin, and metabolic correlates of insulin resistance: a longitudinal study in British children; 1: Prepuberty (EarlyBird 15). Clin Chem 2008 0.83
252 Hepatic VLDL overproduction: is hyperinsulinemia or insulin resistance the culprit? J Clin Endocrinol Metab 2011 0.83
253 Specific elevation in plasma tissue plasminogen activator antigen concentrations in South Asians relative to Europeans. Blood Coagul Fibrinolysis 2003 0.83
254 A specific elevation in tissue plasminogen activator antigen in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 2002 0.83
255 Diabetes: Which risk engines should be used to assess patients with diabetes? Nat Rev Endocrinol 2009 0.83
256 Pharmacotherapy: Statins and new-onset diabetes--the important questions. Nat Rev Cardiol 2012 0.83
257 Serial changes in adiponectin and BNP in ACS patients: paradoxical associations with each other and with prognosis. Clin Sci (Lond) 2009 0.83
258 Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome. J Clin Endocrinol Metab 2003 0.83
259 Personality, socio-economic status and inflammation: cross-sectional, population-based study. PLoS One 2013 0.83
260 PCSK9 SNP rs11591147 is associated with low cholesterol levels but not with cognitive performance or noncardiovascular clinical events in an elderly population. J Lipid Res 2013 0.83
261 A systematic review of event rates in clinical trials in diabetes mellitus: the importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design. Am Heart J 2011 0.82
262 Total cerebral blood flow and mortality in old age: a 12-year follow-up study. Neurology 2013 0.82
263 Non-homologous end-joining pathway associated with occurrence of myocardial infarction: gene set analysis of genome-wide association study data. PLoS One 2013 0.82
264 Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF). Eur J Heart Fail 2012 0.82
265 Impact of ethnicity on metabolic disturbance, vascular dysfunction and atherothrombotic cardiovascular disease. Diabetes Obes Metab 2005 0.82
266 The association of insulin-like-growth factor 1 (IGF-1) with incident coronary heart disease in women: findings from the prospective British Women's Heart and Health Study. Atherosclerosis 2008 0.82
267 Leptin levels and depressive symptoms in people with type 2 diabetes: the edinburgh type 2 diabetes study. Psychosom Med 2011 0.82
268 Adiponectin predicts insulin resistance but not endothelial function in young, healthy adolescents. J Clin Endocrinol Metab 2005 0.82
269 Retinal arteriolar tortuosity and cardiovascular risk factors in a multi-ethnic population study of 10-year-old children; the Child Heart and Health Study in England (CHASE). Arterioscler Thromb Vasc Biol 2011 0.82
270 Which circulating antioxidant vitamins are confounded by socioeconomic deprivation? The MIDSPAN family study. PLoS One 2010 0.82
271 Apolipoprotein E-deficient mice are resistant to the development of collagen-induced arthritis. Arthritis Rheum 2010 0.82
272 Role of adiponectin in matching of fetal and placental weight in mothers with type 1 diabetes. Diabetes Care 2008 0.82
273 Effect of Smoking on Blood Pressure and Resting Heart Rate: A Mendelian Randomization Meta-Analysis in the CARTA Consortium. Circ Cardiovasc Genet 2015 0.82
274 Associations of maternal 25-hydroxyvitamin D in pregnancy with offspring cardiovascular risk factors in childhood and adolescence: findings from the Avon Longitudinal Study of Parents and Children. Heart 2013 0.81
275 Vitamin antioxidants, lipid peroxidation and the systemic inflammatory response in patients with prostate cancer. Int J Cancer 2006 0.81
276 Hyperglycemia has a greater impact on left ventricle function in South Asians than in Europeans. Diabetes Care 2013 0.81
277 A dysglycaemic effect of statins in diabetes: relevance to clinical practice? Diabetologia 2014 0.81
278 Markers of endothelial dysfunction and cerebral blood flow in older adults. Neurobiol Aging 2013 0.81
279 Contrasting associations of insulin resistance with diabetes, cardiovascular disease and all-cause mortality in the elderly: PROSPER long-term follow-up. Diabetologia 2014 0.81
280 Vascular dysfunction and alteration of novel and classic cardiovascular risk factors in mothers of growth restricted offspring. Atherosclerosis 2008 0.81
281 Prenatal exposures and anti-Mullerian hormone in female adolescents: the Avon Longitudinal Study of Parents and Children. Am J Epidemiol 2013 0.81
282 C-reactive protein and genetic variants and cognitive decline in old age: the PROSPER study. PLoS One 2011 0.81
283 Serum C-reactive protein and lipids in ultra-Marathon runners. Am J Cardiol 2004 0.80
284 Behavior of insulin resistance and its metabolic correlates in prepubertal children: a longitudinal study (EarlyBird 32). Diabetes Care 2007 0.80
285 Non-esterified fatty acids impair endothelium-dependent vasodilation in rat mesenteric resistance vessels. Clin Sci (Lond) 2004 0.80
286 Enhancement of endothelial function by pregnancy: inadequate response in women with type 1 diabetes. Diabetes Care 2003 0.80
287 Cardio-metabolic risk factors and cortical thickness in a neurologically healthy male population: Results from the psychological, social and biological determinants of ill health (pSoBid) study. Neuroimage Clin 2013 0.80
288 Walking and inflammatory markers in individuals screened for type 2 diabetes. Prev Med 2008 0.80
289 Infant body composition and adipokine concentrations in relation to maternal gestational weight gain. Diabetes Care 2014 0.80
290 Ethnicity and risk of cardiovascular disease (CVD): 4.8 year follow-up of patients with type 2 diabetes living in Scotland. Diabetologia 2015 0.80
291 Simvastatin prevents inflammation-induced aortic stiffening and endothelial dysfunction. Br J Clin Pharmacol 2010 0.79
292 Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated by thrombin in human monocytes and THP-1 cells in vitro and in pregnant subjects in vivo. Thromb Haemost 2003 0.79
293 Design and baseline characteristics of the PODOSA (Prevention of Diabetes & Obesity in South Asians) trial: a cluster, randomised lifestyle intervention in Indian and Pakistani adults with impaired glycaemia at high risk of developing type 2 diabetes. BMJ Open 2013 0.79
294 Is vitamin D in rheumatoid arthritis a magic bullet or a mirage? The need to improve the evidence base prior to calls for supplementation. Arthritis Rheum 2011 0.79
295 In preeclampsia, maternal third trimester subcutaneous adipocyte lipolysis is more resistant to suppression by insulin than in healthy pregnancy. Hypertension 2014 0.79
296 How low to aim in rheumatoid arthritis? Learning from other disciplines. Ann Rheum Dis 2013 0.79
297 Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis. Lancet Diabetes Endocrinol 2016 0.78
298 Early life socioeconomic status, chronic physiological stress and hippocampal N-acetyl aspartate concentrations. Behav Brain Res 2012 0.78
299 The association of nonalcoholic fatty liver disease with central and peripheral blood pressure in adolescence: findings from a cross-sectional study. J Hypertens 2015 0.78
300 N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetologia 2014 0.78
301 Circulating levels of adiponectin and leptin at 23-25 weeks of pregnancy in women with impaired placentation and in those with established fetal growth restriction. Clin Sci (Lond) 2008 0.78
302 Classification of reported statin intolerance. Curr Opin Lipidol 2015 0.78
303 Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). BMC Geriatr 2011 0.78
304 Homocysteine levels and treatment effect in the PROspective Study of Pravastatin in the Elderly at Risk. J Am Geriatr Soc 2014 0.78
305 Socioeconomic status and the cerebellar grey matter volume. Data from a well-characterised population sample. Cerebellum 2013 0.78
306 Dietary lipids and vascular function: UK Food Standards Agency workshop report. Br J Nutr 2004 0.78
307 N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis: results from the Norfolk Arthritis Registry (NOAR). Ann Rheum Dis 2013 0.78
308 Is it important to measure or reduce C-reactive protein in people at risk of cardiovascular disease? Eur Heart J 2012 0.77
309 Metabolic syndrome criteria: ready for clinical prime time or work in progress? Eur Heart J 2005 0.77
310 Supraphysiological concentrations of estradiol in menopausal women given repeated implant therapy do not adversely affect lipid profiles. Hum Reprod 2002 0.77
311 The changing role of the clinical laboratory in the investigation of polycystic ovarian syndrome. Clin Biochem Rev 2007 0.77
312 Growth hormone replacement reduces C-reactive protein and large-artery stiffness but does not alter endothelial function in patients with adult growth hormone deficiency. Clin Endocrinol (Oxf) 2005 0.77
313 Low vitamin D levels are related to left ventricular concentric remodelling in men of different ethnic groups with varying cardiovascular risk. Int J Cardiol 2012 0.77
314 Nonexercise Equations to Estimate Fitness in White European and South Asian Men. Med Sci Sports Exerc 2016 0.77
315 Event rates in trials of patients with type 2 diabetes. JAMA 2010 0.77
316 Circulating IL-6 concentrations and associated anthropometric and metabolic parameters in South Asian men and women in comparison to European whites. Cytokine 2012 0.77
317 Pre-eclampsia associated with Helicobacter pylori seropositivity. J Hypertens 2006 0.77
318 Insights from apoB: from better diagnosis & therapy to the Medusa Hypothesis. Atheroscler Suppl 2004 0.76
319 SERRS immunoassay for quantitative human CRP analysis. Analyst 2008 0.76
320 More knocks to the oxidation hypothesis for vascular disease? Clin Sci (Lond) 2009 0.76
321 Does rimonabant pull its weight for type 2 diabetes? Lancet 2006 0.76
322 Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk? Clin Endocrinol (Oxf) 2003 0.76
323 QRISK2 validation by ethnic group. Heart 2013 0.76
324 Association of inflammatory mediators with premature atherosclerosis in rheumatoid arthritis and healthy controls: comment on the article by Rho et al. Arthritis Care Res (Hoboken) 2010 0.76
325 Statin treatment of rheumatoid arthritis: comment on the editorial by Ridker and Solomon. Arthritis Rheum 2010 0.75
326 Vitamin D insufficiency. N Engl J Med 2011 0.75
327 Don't rush into testing and treating children. BMJ 2012 0.75
328 Correction: The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study. PLoS Genet 2016 0.75
329 Obesity in children and future cardiometabolic risk: are blood tests necessary? Diabetes Care 2010 0.75
330 Physical Activity Is Prospectively Associated With Adolescent Nonalcoholic Fatty Liver Disease. J Pediatr Gastroenterol Nutr 2016 0.75
331 Metformin and lactic acidosis. Metformin: framed again? BMJ 2009 0.75
332 Polycystic ovarian syndrome, biomarkers, and metformin: research, risk, and reality. J Clin Endocrinol Metab 2008 0.75
333 Metabolic syndrome and diabetes mellitus. Circulation 2004 0.75
334 Response to Effect of serum chloride on mortality in hypertensive patients. Hypertension 2014 0.75
335 Metabolic syndrome, dysglycaemia and vascular disease: making sense of the evidence. Heart 2007 0.75
336 Response to: 'The influence of inflammation in the development of subclinical atherosclerosis in psoriatic arthritis' by Gonzalez-Gay et al. Ann Rheum Dis 2014 0.75
337 Association of N-terminal pro-brain natriuretic peptide with cardiac disease, but not with vascular disease, in systemic lupus erythematosus. Arthritis Rheum 2012 0.75
338 Physical Activity, Sedentary Behavior, and Inflammatory and Hemostatic Markers in Men. Med Sci Sports Exerc 2017 0.75
339 Normal levels of inflammatory markers in treated patients with familial hypercholesterolaemia: a cross-sectional study. JRSM Cardiovasc Dis 2012 0.75
340 The case for diabetes screening: ADDITION-Europe. Lancet 2011 0.75
341 Research digest: cardiac biomarkers for risk prediction. Lancet Diabetes Endocrinol 2016 0.75
342 Women with polycystic ovary syndrome (PCOS) often undergo protracted treatment with metformin and are disinclined to stop: indications for a change in licensing arrangements? Hum Reprod 2004 0.75
343 Research digest: hypoglycaemia and glucose variability. Lancet Diabetes Endocrinol 2017 0.75
344 Erratum. The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes. Diabetes Care 2014;37:295-303. Diabetes Care 2015 0.75
345 Endothelial function in patients with proteinuric primary glomerulonephritis. Nephron Clin Pract 2008 0.75
346 Research digest. Lancet Diabetes Endocrinol 2016 0.75
347 [2016 European Guidelines on cardiovascular disease prevention in clinical practice]. Kardiol Pol 2016 0.75
348 Research digest: more cardiovascular outcome trials in diabetes. Lancet Diabetes Endocrinol 2017 0.75
349 Research digest: NAFLD in the spotlight. Lancet Diabetes Endocrinol 2016 0.75
350 Research digest: topical trials in thyroid disease. Lancet Diabetes Endocrinol 2017 0.75
351 Choice of medical therapy to lower triglycerides in those at risk of pancreatitis. Curr Opin Lipidol 2013 0.75
352 Research digest: the risks of type 2 diabetes at a young age. Lancet Diabetes Endocrinol 2017 0.75
353 Research digest: weight loss to prevent and treat diabetes. Lancet Diabetes Endocrinol 2016 0.75
354 Research digest. Lancet Diabetes Endocrinol 2016 0.75
355 Effects of low-dose continuous combined HRT on vascular function in women with type 2 diabetes. Diab Vasc Dis Res 2004 0.75
356 Unraveling the Directional Link between Adiposity and Inflammation: A Bidirectional Mendelian Randomization Approach. Endocr Rev 2009 0.75
357 Research digest: prediabetes definitions and diabetes prevention. Lancet Diabetes Endocrinol 2017 0.75
358 Tackling obesity in adult primary care. Practitioner 2010 0.75
359 Reproducibility and repeatability of peripheral microvascular assessment using iontophoresis in conjunction with laser Doppler imaging. J Cardiovasc Pharmacol 2007 0.75
360 Managing cardiovascular risk in rheumatoid patients. Am J Cardiol 2012 0.75
361 Lipid metabolism. Curr Opin Lipidol 2013 0.75
362 The G-to-T point mutation in codon 34 of the factor XIII gene and the risk of pre-eclampsia. Blood Coagul Fibrinolysis 2003 0.75
363 Simultaneous activation of the liver X receptors (LXRα and LXRβ) drives murine collagen-induced arthritis disease pathology. Ann Rheum Dis 2011 0.75
364 Statins as novel therapies for osteoporosis? Eur J Obstet Gynecol Reprod Biol 2002 0.75